Home - Boston Life Sciences Times

LATEST ARTICLES

Pharma

AstraZeneca says vaccine 76% effective for 90 days after single dose

Life Sciences Times - February 3, 20210

Pharma

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute

Life Sciences Times - February 2, 20210

Life Sciences

Gilead and the Human Rights Campaign Will Work Together to Combat HIV Epidemic and Promote Transgender Justice

Life Sciences Times - February 2, 20210

Venture Capital

Oxford Finance Provides $47 Million Credit Facility to Averhealth

Life Sciences Times - February 2, 20210

Biotech

Glympse Bio Names Jessica Atkinson Senior Vice President of Business Development

Life Sciences Times - February 2, 20210

Biotech

New England Biolabs and Color Partner to Provide COVID-19 Testing to Biotech Workers Essential to Global Pandemic Response

Life Sciences Times - February 2, 20210

Medtech

Dr. Siddhartha Kadia to Join NuVasive Board of Directors

Life Sciences Times - February 2, 20210

Life Sciences

Life Biosciences appoints Joan Mannick, MD, to lead its research and development

Life Sciences Times - February 2, 20210

Life Sciences

MYND Life Sciences Announces Research Agreement with the University of British Columbia on Major Depressive Disorder

Life Sciences Times - February 2, 20210

Public Health

Bleeding gums may indicate vitamin C deficiency

Life Sciences Times - February 2, 20210

1...848849850...870 Page 849 of 870

Suffolk Appoints Bobby Eagar to Lead Orange County Division and Southern California Healthcare Operations

July 13, 2026

Agenus Secures Up to $340 Million to Advance Phase 3 Colon Cancer Trial

July 13, 2026

Charles River to Provide NGS Testing Services for Arovella’s Cancer Cell Therapy Program

July 13, 2026

Cellares and Sonoma Biotherapeutics Partner to Automate Treg Cell Therapy Manufacturing

July 13, 2026

Most Popular

Suffolk Appoints Bobby Eagar to Lead Orange County Division and Southern California Healthcare Operations

Agenus Secures Up to $340 Million to Advance Phase 3 Colon Cancer Trial

Charles River to Provide NGS Testing Services for Arovella’s Cancer Cell Therapy Program

Cellares and Sonoma Biotherapeutics Partner to Automate Treg Cell Therapy Manufacturing

Recent Comments

EDITOR PICKS

Stoke Therapeutics Appoints Thomas McCauley as Chief Scientific Officer

ZETA Surgical Receives FDA Clearance for Robotic TMS System

PODD Investors Alerted to Securities Class Action Against Insulet

THIS WEEK'S STORIES

LinusBio Launches Consumer Hair Test to Track Environmental Exposures

Onera Health Wins Red Dot Award for Home Sleep Testing System

Cognito Therapeutics Reports Exploratory Alzheimer’s Biomarker Data for Spectris

POPULAR CATEGORY

ABOUT US

FOLLOW US